DNM2 and breast carcinoma: In this study, we have evaluated the localization of expression of dynamin 2 in membranous, cytoplasmic, and nuclear sites of tumor cells for the first time in a series of the breast cancer tissue samples using immunohistochemistry on tissue microarray (TMA) slides, which were related to disease stage and histological grade as well as its aggressiveness.